CNP-T1D (Type 1 Diabetes)

CNP-T1D is a first-in-class therapeutic designed to reprogram the immune system to address the immunological root cause of disease in Type 1 Diabetes, returning balance to the immune system via antigen-specific immune reprogramming to stop immune mediated destruction of pancreatic islet cells.